Vitamins ameliorate secondary mitochondrial failure in neonatal rat brain

Akihito Nakai1, Yukino Shibazaki, Yoshinari Taniuchi

  • 1Tama Nagayama Hospital, Department of Obstetrics and Gynecology, Nippon Medical School, 1-7-1 Nagayama, Tama-City, Tokyo, 206-8512, Japan.

Pediatric Neurology
|August 6, 2002
PubMed

Insights

Combined ascorbic acid and alpha-tocopherol treatment significantly improved secondary mitochondrial dysfunction in immature rat brains following transient intrauterine ischemia. This combination therapy offers greater neuroprotection than individual treatments.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Perinatal Medicine

Background:

  • Transient intrauterine ischemia can cause secondary mitochondrial dysfunction in immature brains.
  • This dysfunction contributes to brain damage in newborns exposed to such events.

Purpose of the Study:

  • To evaluate the efficacy of combined ascorbic acid and alpha-tocopherol in mitigating secondary brain damage.
  • To compare the protective effects of combination therapy versus individual treatments.

Main Methods:

  • Induction of transient intrauterine ischemia in pregnant rats via uterine artery occlusion.
  • Administration of vehicle, ascorbic acid, alpha-tocopherol, or combination therapy before and after ischemia.
  • Assessment of mitochondrial respiration in neocortical tissue of pups delivered via cesarean section.

Main Results:

  • Vehicle treatment reduced mitochondrial activity to 56% of controls.
  • Ascorbic acid or alpha-tocopherol alone improved mitochondrial function to 64% and 62%, respectively.
  • Combined treatment normalized mitochondrial activity to 91% of nonischemic controls.

Conclusions:

  • Combined ascorbic acid and alpha-tocopherol treatment offers superior protection against secondary mitochondrial dysfunction.
  • This combination therapy is more effective than individual antioxidant treatments in this model of perinatal brain injury.